Rocuronium Bromide Injection, Solution
Product Images NDC 82449-001

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Rocuronium Bromide (NDC 82449-001). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Steriscience Specialties Private Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image-carton-1 (Carton Image)

FDA Label Image

Figure 1 (Figure 1)

Figure 1 (Figure 1)
This text provides age ranges in different formats: "1-12 years", "65 years", and "18-64 years". These age ranges can be used for categorizing or filtering information based on different age groups.*
FDA Label Image

Figure 2 (Figure 2)

FDA Label Image

Figure 3 (Figure 3)

FDA Label Image

Structure Rocuronium (Structure Rocuronium)

FDA Label Image

Vial-label-roc-br (Vial Image)

Vial-label-roc-br (Vial Image)
This is a label for Rocuronium Bromide Injection, containing 50 mg in 5 mL, with a concentration of 10 mg/mL, for intravenous use only. The product is a paralyzing agent and comes in a 5 mL multiple-dose vial. It includes warnings about the need for immediate availability of artificial respiration and non-pyrogenic nature. Storage instructions indicate room temperature, protection from light, and avoidance of freezing. After opening, the compound must be used or discarded within 30 days. The manufacturer is mentioned as Sandoz Inc.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.